BU-NOT-SET

CONTACT US
Fixed dose combinations - for improved patient compliance
  • Drug product
mini-tablets
Fact sheet
The current state of contract manufacturing
  • Industry trends
Eyes
Insight
The potential impact of Brexit on patient safety
  • Industry trends
Eyes
Insight
EU FMD: After the deadline
  • Manufacturing
Eyes
Insight
The importance of supply chain security
  • Manufacturing
Eyes
Insight
ADC development: setbacks and key developments
  • Drug substance
Lab equipment
Insight
Cytotoxic unsaturated electrophilic compounds commonly target the ubiquitin proteasome system
  • Drug substance
Eyes
Insight
CDMO trends: Drug development and industry consolidation
  • Industry trends
Eyes
Insight
Consolidation in the CDMO Market
  • Industry trends
Eyes
Insight
Insight
  • Drug product
  • Manufacturing
Using blow-fill-seal technology for biologic and vaccine delivery
Webinar
Webinar: Understanding the benefits of blow-fill-seal unidose for ophthalmics, as an alternative to glass vials
Insight
  • Industry trends
  • Manufacturing
A leading global CDMO, renowned for its reliable & on-time offerings
Insight
  • Biologics
Navigating challenges in progressing breakthrough RNA therapeutics
Report
  • Sustainability
Sustainability report 2023
Insight
  • Industry trends
  • Manufacturing
Navigating pre-filled syringe filling complexities
Insight
  • Industry trends
  • Manufacturing
New product introduction: key to getting innovations from pilot to product
Case study
  • Drug product
Tackling antimicrobial resistance
Insight
  • Biologics
A new centre for continuous mRNA manufacturing